Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pathologe ; 31(1): 60-6, 2010 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-19823827

RESUMEN

Myxoid/round cell liposarcoma are characterized by typical chromosomal translocations. This genetic alteration might result in specific gene-expression profiles in this tumor entity. To identify over-expressed genes in myxoid/round cell liposarcoma DNA microarray analysis was performed on four tumors and four samples of adult fat tissue. Genes ret, cdk4, cyclin D2 and c-myc showed over-expression by means of microarray analysis and Northern blotting. Immunohistochemistry demonstrated cytoplasmic localization of associated proteins in 36 different tumors. The localization of ret was seen in endothelial cells of plexiform vasculature in addition to its accumulation in tumor cells (25% of cases). The results show an over-expression of cdk4, cyclin D2, c-myc and ret on both the transcriptional and protein level in myxoid/round cell liposarcoma. For cyclin D2 and ret this finding has not been reported in this tumor type. The increase of ret on transcriptional level might be explained by its expression in endothelium in intratumoral plexiform blood vessels. For the molecular pathogenesis of myxoid/round cell liposarcoma our findings imply the involvement of these four genes in the deregulation of the cell cycle, especially as cdk4 and cyclin D2 are target genes of c-myc.


Asunto(s)
Biomarcadores de Tumor/genética , Regulación Neoplásica de la Expresión Génica/genética , Marcadores Genéticos/genética , Liposarcoma Mixoide/genética , Liposarcoma Mixoide/patología , Liposarcoma/genética , Liposarcoma/patología , Análisis de Secuencia por Matrices de Oligonucleótidos , Neoplasias de los Tejidos Blandos/genética , Neoplasias de los Tejidos Blandos/patología , Ciclina D2/genética , Quinasa 4 Dependiente de la Ciclina/genética , Perfilación de la Expresión Génica , Humanos , Liposarcoma/clasificación , Liposarcoma Mixoide/clasificación , Técnicas de Diagnóstico Molecular , Pronóstico , Proteínas Proto-Oncogénicas c-myc/genética , Proteínas Proto-Oncogénicas c-ret/genética , Neoplasias de los Tejidos Blandos/clasificación , Translocación Genética/genética
2.
Pathologe ; 26(5): 331-7, 2005 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-16032388

RESUMEN

The case of a soft tissue myoepithelioma is presented including clinicopathologic, ultrastructural, and genetic findings. A 30-year-old male patient suffered from a soft tissue tumor within the deep soft tissues of the right lower leg measuring 13.2 x 8.2 x 9 cm. Histologically, the lesion was diagnosed as a myoepithelioma displaying a lobulated architecture with cords and nests of epithelioid and spindle cells without cytologic atypia lying within a fibromyxoid and partly chondroid matrix; immunohistochemistry was positive for pancytokeratin, S100-protein, calponin and partly for GFAP and EMA. Ultrastructural analysis revealed glycogen deposits and cell-membrane-associated plaque structures, whereas true myofilaments could not be identified (with immunohistochemistry being negative for actin). Using comparative genomic hybridization (CGH), a gain of chromosome Y was detected. A loss on 17p could not be detected unambiguously. However, based on the low resolution of CGH a small loss cannot be excluded. The patient was free of disease 25 months following complete tumor resection. Myoepitheliomas/mixed tumors of deep soft tissue represent rare soft tissue lesions that may reach a considerable size and may mimic other soft tissue tumors or sarcomas. Based on a local relapse rate of approximately 20% according to the literature, a complete resection with thorough follow-up should be recommended.


Asunto(s)
Mioepitelioma/patología , Neoplasias de los Tejidos Blandos/patología , Adulto , Proteínas de Unión al Calcio/metabolismo , ADN de Neoplasias/metabolismo , Proteína Ácida Fibrilar de la Glía/metabolismo , Humanos , Inmunohistoquímica , Pierna , Masculino , Proteínas de Microfilamentos , Mioepitelioma/genética , Mioepitelioma/ultraestructura , Hibridación de Ácido Nucleico , Proteínas S100/metabolismo , Neoplasias de los Tejidos Blandos/genética , Neoplasias de los Tejidos Blandos/ultraestructura , Calponinas
3.
Pathologe ; 26(2): 96-110, 2005 Mar.
Artículo en Alemán | MEDLINE | ID: mdl-15657685

RESUMEN

Morphological, ultrastructural, and immunohistochemical findings of 12 diffuse type-tenosynovial giant cell tumors/pigmented villonodular synovitis are presented compared to 30 localized tenosynovial giant cell tumors (giant cell tumor of tendon sheath). Diffuse-type-tenosynovial giant cell tumor is characterized by a striking vascularisation pattern composed of densely arranged thin-walled, partly slit-like and partly hyalinized small blood vessels within the papillary synovial fronds. These vessels may show abnormal structures with incompletely arranged endothelial cells/pericytes. The fibrohistiocytic tumor cells probably cause considerable compression/distortion or destruction of the small vessels which might be responsible for an increased blood deposition and massive hemosiderosis. Accompanying multinucleated osteoclast-like giant cells seemingly are recruited from circulating blood monocytes. Microhemorrhagic foci with multinucleated giant cells could be detected in 83% of diffuse-type and 67% of localized-type tumors. Apart from the described vessels, typical morphological findings in diffuse-type tenosynovial giant cell tumors included "giant" hemosiderotic granules, (at least 2-3 times the diameter of an erythrocyte) "giant" siderophages, pseudoalveolar clefts and irregularly anastomosing synovial fronds. Neither mitotic rate nor the amount of giant cells/amount of nuclei of giant cells revealed statistically significant differences between localized-type and diffuse-type of tenosynovial giant cell tumor. Immunohistochemically, the diffuse-type exhibited focal expression of CD31 (in 75% of tumors) and calretinin (in 63%) besides CD68-staining.


Asunto(s)
Tumores de Células Gigantes/patología , Neoplasias de los Tejidos Blandos/patología , Membrana Sinovial/patología , Tendones/patología , Antígenos CD/análisis , Tumores de Células Gigantes/ultraestructura , Humanos , Inmunohistoquímica , Microscopía Electrónica , Mitosis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA